NCT07772804Not yet recruiting
Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation
Incidence of Postoperative Pulmonary Complications Between Mechanical Power-based Versus Conventional Lung Protective Ventilation During One-lung Ventilation: a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
The goal of this clinical trial is to determine whether a mechanical power-based lung-protective ventilation strategy during one-lung ventilation reduces the incidence of postoperative pulmonary complications in adult patients undergoing lung resection surgery. Mechanical power during pressure-regulated volume control mode is calculated using the formula below. Mechanical power (J/min) = 0.098 x respiratory rate x tidal volume x (inspiratory airway pressure above positive end-expiratory pressure + positive end-expiratory pressure) The main questions it aims to answer are: * Does a mechanical power-based lung-protective ventilation strategy significantly lower the incidence of major postoperative pulmonary complications compared to conventional ventilation? * How does this strategy impact intraoperative hemodynamic and vital profiles (e.g., blood pressure, cardiac output, vasopressor requirements, and blood oxygen saturation) during one-lung ventilation? Participants will: * Be randomized to receive either a mechanical power-based lung-protective ventilation strategy or a conventional lung-protective ventilation strategy exclusively during one-lung ventilation. * Be closely monitored for the occurrence of major postoperative pulmonary complications (atelectasis, pneumonia, acute respiratory distress syndrome, and pulmonary aspiration) and adverse events for 1 month postoperatively.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 164 (estimated)
- First submitted
- 14 Aug 2026
- Start date
- 30 Aug 2026
- Primary completion date
- 30 Aug 2027
- Lead sponsor
- Samsung Medical Center
- Diseases
- Lung cancer
- NCT number
- NCT07772804
What you commit to
- Study type: Interventional
- Planned participants: 164
- From 30 Aug 2026 to the primary completion date, 30 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior history of thoracic surgery
- Emergency surgery
Other
- Pregnancy or lactation
- Known contraindication to one-lung ventilation
- Inability to provide informed consent or cooperate with the study protocol
Who the study is looking for
- American Society of Anesthesiologists (ASA) physical status I-III
- Elective thoracic surgery requiring lung lobectomy under one-lung ventilation
- Age 18 years or older
- Written informed consent obtained from the patient
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Samsung Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.